CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 60 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $185,000 | -69.3% | 69,435 | -50.0% | 0.04% | -38.7% |
| Q4 2021 | $602,000 | +70.5% | 138,870 | +100.0% | 0.06% | -19.5% |
| Q3 2021 | $353,000 | -51.8% | 69,435 | -40.0% | 0.08% | -41.7% |
| Q2 2021 | $733,000 | -18.0% | 115,768 | +0.1% | 0.13% | -19.0% |
| Q1 2021 | $894,000 | +96.5% | 115,647 | +66.6% | 0.16% | +68.0% |
| Q4 2020 | $455,000 | -1.5% | 69,435 | 0.0% | 0.10% | -20.5% |
| Q3 2020 | $462,000 | -20.1% | 69,435 | 0.0% | 0.12% | -17.0% |
| Q2 2020 | $578,000 | -24.0% | 69,435 | +17.7% | 0.15% | -27.9% |
| Q1 2016 | $761,000 | – | 59,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners IX LLC | 4,244,381 | $43,378,000 | 100.00% |
| VHCP Management II, LLC | 577,831 | $5,905,000 | 3.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 71,366 | $729,000 | 2.45% |
| Casdin Capital, LLC | 234,179 | $2,392,000 | 2.38% |
| BVF INC/IL | 606,138 | $6,192,000 | 1.32% |
| Opaleye Management Inc. | 160,000 | $1,634,000 | 1.09% |
| Redmile Group, LLC | 733,899 | $7,497,000 | 0.72% |
| VHCP Management, LLC | 64,200 | $656,000 | 0.68% |
| Montecito Bank & Trust | 146,544 | $1,497,000 | 0.63% |
| Cormorant Asset Management, LP | 371,636 | $3,796,000 | 0.54% |